FOLH1 and cholangiocarcinoma: (20) reported that 161 of 203 patients with cholangiocarcinoma (79.3%) and 185 of 213 patients with HCC (86.8%) showed positive PSMA expression, mainly in the neovascular endothelial cells surrounding the tumor.